| Quarter | Prior | Estimate | Actual | Surprise | |
|---|---|---|---|---|---|
| Q1 2020 After-Hours | EPS: REV: | 0.01 166.823M | |||
| Q4 2019 After-Hours | EPS: REV: | -0.09 158.356M | |||
| Q3 2019 After-Hours | EPS: REV: | 0.18 212.575M | |||
| Q2 2019 After-Hours | EPS: REV: | 0.12 204.625M | |||
| Q1 2019 After-Hours | EPS: REV: | -0.02 164.262M | 159.58M | 0.01 166.823M | 4.54% |
| Q4 2018 After-Hours | EPS: REV: | -0.01 163.266M | -0.07 155.86M | -0.09 158.356M | 28.57% 1.6% |
| Q3 2018 After-Hours | EPS: REV: | 0.02 163.26M | 0.11 204.41M | 0.18 212.575M | 63.64% 3.99% |
| Q2 2018 After-Hours | EPS: REV: | -0.04 150.329M | 0.07 186.08M | 0.12 204.625M | 71.43% 9.97% |
| Q1 2018 After-Hours | EPS: REV: | -0.06 145.99M | -0.02 164.262M | -66.67% 12.52% | |
| Q4 2017 Pre-Market | EPS: REV: | -0.05 128.031M | -0.01 159M | -0.01 163.266M | 2.68% |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- Barnes & Noble Education Reports Big Losses In Q4 Earnings
- FactSet Reports Q3 Earnings Beats, Shares Rise
- Lennar Trades Higher After Q2 Earnings Beat
- The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership
- Q4 Earnings Outlook For FedEx